When the E-cadherin protein is activated, FOXA2 draws the transcriptional corepressor TLE3 to the promoter of ZEB2 to suppress its expression, which can effectively hinder the EMT of breast cancer cells [118,119,120,121]. Here, FOXA2 is linked to breast carcinoma.